Tyenne 20 mg/mL concentrate for solution for infusion

Active Ingredient
Strength
  • Tocilizumab: 162 mg
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/23/1754/001 162 mg L04AC07 Concentrate for solution for infusion
EU/1/23/1754/002 162 mg L04AC07 Concentrate for solution for infusion
EU/1/23/1754/003 162 mg L04AC07 Concentrate for solution for infusion
EU/1/23/1754/004 162 mg L04AC07 Concentrate for solution for infusion
EU/1/23/1754/005 162 mg L04AC07 Concentrate for solution for infusion
EU/1/23/1754/006 162 mg L04AC07 Concentrate for solution for infusion
Licence number
EU/1/23/1754/001
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/002
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/003
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/004
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/005
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/006
Strength
162 mg
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion

Fresenius Kabi Ltd

Unit 3B Fingal Bay Business Park, Balbriggan, Co. Dublin, Ireland, K32YK12

Telephone
+35318413030